2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow QPI-1002: new trials by email Literature Review of QPI-1002 trials Research Report on QPI-1002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery QPI-1002, Placebo - Acute Kidney Injury | Phase 2 | Completed | Quark Pharmaceuticals | 341 | 2015-12-01 | 2019-01-10 |
| I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation I5NP, Saline - Delayed Graft Function, Other Complication of Kidney Transplant | Phase 1 / Phase 2 | Completed | Quark Pharmaceuticals | 374 | 2008-12-01 | 2014-09-18 |
Acute Kidney Injury (1) · Delayed Graft Function (1)
Canada (2) · Germany (2) · United States (2) · France (1) · Spain (1)
Elizabeth Squiers, M.D. (1) · Shai Erlich, Ph.D. (1)